Status: Phase 2
Entry Type: Unknown
Molecule Category: Salt
Parent Compound: LISDEXAMFETAMINE

Indications

Mesh Heading Maximum Phase Reference
Multiple Sclerosis; Sclerosis Phase 2 ClinicalTrials

Related Entries

Parent